Hematologic Malignancy Fusions

Hematologic Malignancy Fusions is a gene fusion construct representing recurrent chromosomal rearrangements that drive oncogenic mechanisms specifically in blood cell lineages, distinguished from solid tumor fusions by their unique molecular pathologies and hematopoietic context.

305

Publications

18.7K

Citations

2.1K

Authors

621

Institutions

Publications per year

2017–2026

43

Authors

2.1K

  1. YH
    Yasuhide Hayashi

    The University of Tokyo, Japan

    17 publications · 1.2K citations

    16

    h-index

  2. TT
    Tomohiko Taki

    Kyoto Prefectural University of Medicine, Japan

    16 publications · 899 citations

    15

    h-index

  3. NC
    Nicholas C.P. Cross

    University of Southampton, United Kingdom

    13 publications · 832 citations

    13

    h-index

  4. BJ
    Bertil Johansson

    Lund University, Sweden

    8 publications · 412 citations

    8

    h-index

  5. AR
    Andreas Reiter

    Heidelberg University, Germany

    7 publications · 659 citations

    7

    h-index

1–5 of 2.1K

Venues

  1. Genes Chromosomes and Cancer

    42 publications · 1.9K citations

    29

    h-index

  2. British Journal of Haematology

    BJH · 33 publications · 1.4K citations

    25

    h-index

  3. PubMed

    Repository · 24 publications · 1.7K citations

    21

    h-index

  4. Proceedings of the National Academy of Sciences

    PNAS · 17 publications · 3.2K citations

    17

    h-index

  5. Blood

    16 publications · 1.2K citations

    15

    h-index

1–5